Transcranial Magnetic Stimulation in Persons Younger Than the Age of 18

Department of Psychiatry, Division of Child and Adolescent Psychiatry, Louisiana State University Health Science Center, School of Medicine, New Orleans, Louisiana 70112-2822, USA.
Journal of Ect (Impact Factor: 1.39). 07/2005; 21(2):88-95. DOI: 10.1097/01.yct.0000162556.02720.58
Source: PubMed


To review the use of transcranial magnetic stimulation (single-pulse TMS, paired TMS, and repetitive TMS [rTMS]) in persons younger than the age of 18 years. I discuss the technical differences, as well as the diagnostic, therapeutic, and psychiatric uses of TMS/rTMS in this age group.
I evaluated English-language studies from 1993 to August 2004 on nonconvulsive single-pulse, paired, and rTMS that supported a possible role for the use of TMS in persons younger than 18. Articles reviewed were retrieved from the MEDLINE database and Clinical Scientific index.
The 48 studies reviewed involved a total of 1034 children ages 2 weeks to 18 years; 35 of the studies used single-pulse TMS (980 children), 3 studies used paired TMS (20 children), and 7 studies used rTMS (34 children). Three studies used both single and rTMS. However, the number of subjects involved was not reported.
Single-pulse TMS, paired TMS, and rTMS in persons younger than 18 has been used to examine the maturation/activity of the neurons of various central nervous system tracts, plasticity of neurons in epilepsy, other aspects of epilepsy, multiple sclerosis, myoclonus, transcallosal inhibition, and motor cortex functioning with no reported seizure risk. rTMS has been applied to psychiatric disorders such as ADHD, ADHD with Tourette's, and depression. Adult studies support an antidepressant effect from repetitive TMS, but there is only one study that has been reported on 7 patients that used rTMS to the left dorsal prefrontal cortex on children/adolescents with depression (5 of the 7 subjects treated responded). Although there are limited studies using rTMS (in 34 children), these studies did not report significant adverse effects or seizures. Repetitive TMS safety, ethical, and neurotoxicity concerns also are discussed.

46 Reads
  • Source
    • "Only participants under the age of 45 years were included to avoid prolonged effects of long standing epilepsy and maintain homogeneity across groups. Participants under the age of 14 years were excluded as their normal single and paired pulse TMS values are non-comparable to older participants, nor have been established in children with epilepsy (Garvey and Mall, 2008; Quintana, 2005). This excluded patients with focal epilepsies of childhood such as focal epilepsy with centro-temporal spikes. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective To investigate whether cortical excitability measures on transcranial magnetic stimulation (TMS) differed between groups of patients with different focal epilepsy syndromes. Methods 85 patients with focal epilepsy syndromes divided into temporal and extra-temporal lobe epilepsy were studied. The cohorts were further divided into drug naïve- new onset, refractory and seizure free groups. Motor threshold (MT) and paired pulse TMS at short (2, 5, 10, 15 ms) and long (100 - 300 ms) interstimulus intervals (ISIs) were measured. Results were compared to those of 20 controls. Results Cortical excitability was higher at 2 & 5 ms and 250, 300 ms ISIs (p< 0.01) in focal epilepsy syndromes compared to controls however significant inter-hemispheric differences in MT and the same ISIs were only seen in the drug naïve state early at onset and were much more prominent in temporal lobe epilepsy. Conclusion Disturbances in cortical excitability are more confined to the affected hemisphere in temporal lobe epilepsy but only early at onset in the drug naïve state. Significance Group TMS studies show that cortical excitability measures are different in temporal lobe epilepsy and can be distinguished from other focal epilepsies early at onset in the drug naïve state. Further studies are needed to determine whether these results can be applied clinically as the utility of TMS in distinguishing between epilepsy syndromes at an individual level remains to be determined.
    Clinical Neurophysiology 06/2014; 126(2). DOI:10.1016/j.clinph.2014.05.029 · 3.10 Impact Factor
  • Source
    • "Two previous reviews (Quintana, 2005; Croarkin et al., 2011) gave an overview of the application of rTMS in children and adolescents. Here, we provide the reader with an updated state of the art of application of non-invasive brain stimulation in general (rTMS and tDCS) in pediatric populations. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In the last decades interest in application of non-invasive brain stimulation for enhancing neural functions is growing continuously. However, the use of such techniques in pediatric populations remains rather limited and mainly confined to the treatment of severe neurological and psychiatric diseases. In this article we provide a complete review of non-invasive brain stimulation studies conducted in pediatric populations. We also provide a brief discussion about the current limitations and future directions in a field of research still very young and full of issues to be explored.
    Frontiers in Systems Neuroscience 11/2013; 7:94. DOI:10.3389/fnsys.2013.00094
  • Source
    • "Only participants aged 14 years and above were included. This is because normal single-and paired-pulse TMS values in children under this age are noncomparable to older participants and have not been established in children with epilepsy [18] [19]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective: We used transcranial magnetic stimulation (TMS) to investigate motor cortical excitability changes in relation to blood glucose levels. Methods: Twenty-two drug-naïve patients with epilepsy [11 generalized and 11 focal] and 10 controls were studied twice on the same day; first after 12h of fasting and then 2h postprandial. Motor threshold and paired-pulse TMS at a number of short and long interstimulus intervals were measured. Serum glucose levels were measured each time. Results: Decreased long intracortical inhibition was seen in patients and controls during fasting compared to postprandial studies. This effect was much more prominent in patients with generalized epilepsy (with effect sizes of up to 0.8) in whom there was also evidence of increased intracortical facilitation (effect size: 0.3). Conclusion: Cortical excitability varies with fluctuations in blood glucose levels. This variation is more prominent in patients with epilepsy. Decreased glucose levels may be an important physiological seizure trigger.
    Epilepsy & Behavior 04/2013; 27(3):455-460. DOI:10.1016/j.yebeh.2013.03.015 · 2.26 Impact Factor
Show more